HBK Sorce Advisory’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,924
| Closed | -$290K | – | 455 |
|
|
2019
Q3 | $290K | Sell |
2,924
-871
| -23% | -$82.8K | 0.03% | 332 |
|
|
2019
Q2 | $351K | Buy |
3,795
+130
| +4% | +$12.3K | 0.03% | 300 |
|
|
2019
Q1 | $346K | Sell |
3,665
-4,999
| -58% | -$437K | 0.03% | 314 |
|
|
2018
Q4 | $555K | Sell |
8,664
-364
| -4% | -$26.9K | 0.06% | 205 |
|
|
2018
Q3 | $808K | Buy |
9,028
+1,220
| +16% | +$108K | 0.09% | 156 |
|
|
2018
Q2 | $620K | Sell |
7,808
-3,251
| -29% | -$270K | 0.07% | 195 |
|
|
2018
Q1 | $987K | Sell |
11,059
-3,622
| -25% | -$348K | 0.12% | 121 |
|
|
2017
Q4 | $1.53M | Buy |
14,681
+1,598
| +12% | +$180K | 0.18% | 93 |
|
|
2017
Q3 | $1.91M | Buy |
13,083
+69
| +0.5% | +$9.4K | 0.29% | 56 |
|
|
2017
Q2 | $1.69M | Buy |
13,014
+144
| +1% | +$17.6K | 0.27% | 60 |
|
|
2017
Q1 | $1.6M | Sell |
12,870
-316
| -2% | -$37.8K | 0.27% | 56 |
|
|
2016
Q4 | $1.53M | Sell |
13,186
-1,309
| -9% | -$146K | 0.28% | 60 |
|
|
2016
Q3 | $1.51M | Buy |
14,495
+518
| +4% | +$56.1K | 0.3% | 55 |
|
|
2016
Q2 | $1.38M | Sell |
13,977
-334
| -2% | -$34.5K | 0.3% | 57 |
|
|
2016
Q1 | $1.43M | Buy |
14,311
+7,731
| +117% | +$796K | 0.34% | 48 |
|
|
2015
Q4 | $788K | Buy |
6,580
+14
| +0.2% | +$1.62K | 0.21% | 75 |
|
|
2015
Q3 | $710K | Sell |
6,566
-1,032
| -14% | -$128K | 0.23% | 62 |
|
|
2015
Q2 | $879K | Sell |
7,598
-249
| -3% | -$28.5K | 0.3% | 54 |
|
|
2015
Q1 | $905K | Buy |
7,847
+764
| +11% | +$91.3K | 0.31% | 53 |
|
|
2014
Q4 | $792K | Buy |
7,083
+681
| +11% | +$71.8K | 0.27% | 63 |
|
|
2014
Q3 | $607K | Buy |
6,402
+2,344
| +58% | +$212K | 0.22% | 69 |
|
|
2014
Q2 | $349K | Sell |
4,058
-60
| -1% | -$4.56K | 0.12% | 114 |
|
|
2014
Q1 | $287K | Hold |
4,118
| – | – | 0.1% | 130 |
|
|
2013
Q4 | $348K | Hold |
4,118
| – | – | 0.13% | 111 |
|
|
2013
Q3 | $317K | Sell |
4,118
-4,118
| -50% | -$289K | 0.13% | 112 |
|
|
2013
Q2 | $482K | Buy |
+8,236
| New | +$496K | 0.1% | 137 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
HBK Sorce Advisory's CELG Position: Q4 2019 in Review
HBK Sorce Advisory sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,924 shares — an estimated $290K sold.
HBK Sorce Advisory first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.91M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- HBK Sorce Advisory reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- HBK Sorce Advisory sold 2,924 Celgene Corp shares in Q4 2019, an estimated $290K.
- HBK Sorce Advisory first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- HBK Sorce Advisory's Celgene Corp position peaked at $1.91M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on HBK Sorce Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.